-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Verona Pharma plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
- Verona Pharma plc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $250K, a 468% increase year-over-year.
- Verona Pharma plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.97M, a 254% increase year-over-year.
- Verona Pharma plc annual Income Tax Expense (Benefit) for 2023 was $474K, a 87.4% increase from 2022.
- Verona Pharma plc annual Income Tax Expense (Benefit) for 2022 was $253K.
- Verona Pharma plc annual Income Tax Expense (Benefit) for 2021 was -$18K, a 112% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)